THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY published 11 principles and detailed guidance to the Centers for Medicare & Medicaid Services as it implements the Merit-based Incentive Payment System and Alternative Payment Models under the Medicare Access and CHIP Reauthorization on Act of 2015, which replaced the Sustainable Growth Rate formula.
Three years ago, researchers from Memorial Sloan Kettering Cancer Center published stunning results: For the 5% of rectal cancer patients whose tumors are mismatch-repair deficient, neoadjuvant dostarlimab-gxly (Jemperli) has the makings of a silver bullet.
